CENPJ

Across TCGA pan-cancer cohorts, CENPJ mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CENPJ data layer compared with 28 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CENPJ mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated CENPJ expression acts as an unfavorable survival marker.

UCEC and LSCC are the cancer types where CENPJ mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.931	1.000	.028	12	view →
LSCC	OS	Tertile	III,IV	0.586	1.000	.044	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CENPJ–UCEC (DFS)

Open the UCEC breakdown →